Greenberg Traurig, LLP has more than 2750 attorneys in 48 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2024 BTI “Leading Edge Law Firm” for delivering on client expectations for the future and is consistently among the top firms on the Am Law Global 100 and NLJ 500.

Greenberg Traurig's Life Sciences & Medical Technology Group comprises attorneys with multidisciplinary and practical skills, aiding clients in diverse technologies and product solutions. Start-ups, large multinational public companies, research organizations, and not-for-profit care providers, as well as investors, venture capital funds, and public agencies, look to us to guide them from discovery through commercialization and product marketing. The team is positioned to provide innovative and informed legal advice with the combined experience of the firm’s health care, intellectual property, governmental affairs, regulatory, corporate, real estate, litigation, products liability, and employment professionals. Greenberg Traurig handles transactional and litigation matters and representation before administrative and regulatory agencies, and frequently advise on FDA-related matters. Together, our attorneys and governmental professionals help our clients advance their products from the lab to the marketplace.